FICPI, the International Federation of Intellectual Property Attorneys, broadly representative of the free profession throughout the world, assembled at its Executive Committee held in London, United Kingdom, 2 to 4 October 2023, passed the following resolution:
FICPI has followed the work of the IGC since 2001. In 2004, we passed the attached resolution (EXCO/IT04/RES/001) reflecting our views on the proposals at the time.
Following the intensive discussions at the Special Session of the IGC 4 to 8 September 2023 at which we were represented, and ahead of the Diplomatic Conference we reiterate our support for the proposed treaty.
In particular, we wish to emphasize the following key requests from our previous resolution, that the provisions relating to genetic resources should:
1| Clearly and precisely define the requirements for a declaration in a patent application of the source of any genetic material on which the invention is based;
2| Require the applicant to identify in such a declaration only the source from which the genetic material was actually obtained by the inventor;
5| Entitle the applicant to an opportunity to rectify any failure to comply properly with the declaration requirements, and regulate that the consequence of any ultimate failure to meet such requirements shall not, in the absence of fraudulent intent, be invalidation or unenforceability of the patent.
As a refinement to our previous position regarding the retroactivity of any provisions, we agree with the proposed provision of Article 5 that contracting parties “shall not impose the obligations of this instrument in relation to patent applications which have been filed prior to that Contracting Party’s ratification of or accession to this instrument, subject to national laws that existed prior to such ratification or accession.”